MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
MAIA is expected to report earnings to rise 5.56% to -18 cents per share on November 04
Q3'25
Est.
$-0.19
Q2'25
Beat
by $0.07
Q1'25
Beat
by $0.02
Q4'24
Beat
by $0.03
Q3'24
Beat
by $0.12
The last earnings report on August 18 showed earnings per share of -18 cents, beating the estimate of -25 cents. With 93.76K shares outstanding, the current market capitalization sits at 52.13M.
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. MAIA showed earnings on August 18, 2025. You can read more about the earnings report here.